Monkeypox in the New York metropolitan area, Summer 2022
Gnanaprakasam, R.; Keller, M.; Glassman, R.; El Khoury, M. Y.; Chen, D. S.; Feola, N.; Feldman, J.; Chaturvedi, V.
Show abstract
Early in the 2022 Monkeypox global outbreak, caseloads in the New York metropolitan area climbed rapidly before other US urban areas. We summarize our monkeypox clinical experience detecting, treating, and vaccinating during a quickly evolving emerging infection. Statements Ethical statementInstitutional Review Board exemption was granted for this study. Funding statementNo funding was obtained Conflict of interestNone Authors contributionsEach author actively participated in data collection, analysis and editing of the manuscript. CollaboratorsNone
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The changing epidemiology of human monkeypox – a potential threat? A systematic review 94%
- The risk and risk factors of chikungunya virus infection and rheumatological sequelae in a cohort of U.S. Military Health System beneficiaries: implications for the vaccine era 92%
- Patient insights research exploring disease awareness, patient life experience, and current management of visceral leishmaniasis in Bihar, India 92%
Similar papers in this journal
- Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals 92%
- Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization 92%
- Evaluating the accuracy of self-collected swabs for the diagnosis of monkeypox 92%
Similar papers in this journal
- Homologous and heterologous boosting of the ChAdOx1-S1-S COVID-19 vaccine with the SCB-2019 vaccine candidate: a randomized, observer-blinded, controlled, phase 2 study 92%
- HIV Treatment Outcomes In Rural Georgia Using Telemedicine 92%
- CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants 91%
Similar papers in this journal
- Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia 92%
- In-Hospital Survival of Adults with HIV-Associated Cryptococcal Meningitis in Tanzania: A Retrospective Comparison of Amphotericin B-based Regimen and Fluconazole Monotherapy 92%
- Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults 92%
Similar papers in this journal
- Safety and immunogenicity of a heterologous booster of protein subunit vaccine MVC-COV1901 after two doses of adenoviral vector vaccine AZD1222 92%
- Immunogenicity and adverse events of priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) followed by boosting the ChAdOx1 nCoV-19 vaccine 92%
- Retention of Neutralizing response against SARS-CoV-2 Omicron variant in Sputnik V vaccinated individuals 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.